UBS AM’s Nutrien NTR Stock Holding History

UBS AM’s Portfolio NTR Stock Details NTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$364K	Buy	4,820 +2,806	+139%	+$200K	﹤0.01%	2620
2025 Q4	$124K	Buy	+2,014	New	+$119K	﹤0.01%	2510
2025 Q3	–	Sell	-752,322	Closed	-$43.8M	–	2484
2025 Q2	$43.8M	Buy	752,322 +15,326	+2%	+$866K	0.01%	739
2025 Q1	$36.6M	Buy	736,996 +7,194	+1%	+$368K	0.01%	754
2024 Q4	$32.7M	Sell	729,802 -45,766	-6%	-$2.17M	0.01%	780
2024 Q3	$37.3M	Sell	775,568 -62,437	-7%	-$3.01M	0.01%	746
2024 Q2	$42.7M	Buy	+838,005	New	+$45.9M	0.01%	652
2020 Q1	–	Sell	-879,224	Closed	-$42.1M	–	2506
2019 Q4	$42.1M	Buy	879,224 +873,555	+15,409%	+$42.2M	0.03%	582
2019 Q3	$283K	Buy	5,669 +4,903	+640%	+$250K	﹤0.01%	2477
2019 Q2	$41K	Hold	766	–	–	﹤0.01%	2703
2019 Q1	$40.4K	Buy	766 +68	+10%	+$3.54K	﹤0.01%	2625
2018 Q4	$32.8K	Buy	698 +654	+1,486%	+$34.1K	﹤0.01%	2605
2018 Q3	$2.54K	Sell	44 -1,888,233	-100%	-$105M	﹤0.01%	2728
2018 Q2	$103M	Sell	1,888,277 -17,477	-0.9%	-$867K	0.08%	289
2018 Q1	$90M	Buy	+1,905,754	New	+$95.4M	0.07%	309

Other funds holding NTR

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

UBS AM's NTR Position: Q1 2026 in Review

UBS AM increased its Nutrien (NTR) stake by 139% in Q1 2026, buying an estimated $200K and bringing the position to 4,820 shares worth $364K. The position accounts for ﹤0.01% of the portfolio, ranked #2620.

UBS AM first reported a position in NTR in Q1 2018 and has held it in 15 quarters since. The position peaked at $103M in Q2 2018. 747 funds tracked by Wall St. Rank hold NTR as of Q1 2026.

UBS AM held 4,820 shares of Nutrien worth $364K as of Q1 2026.
UBS AM bought 2,806 Nutrien shares in Q1 2026, an estimated $200K.
Nutrien made up ﹤0.01% of UBS AM's portfolio in Q1 2026, its #2620 holding.
UBS AM first reported a position in Nutrien in Q1 2018 and has held it in 15 quarters since.
UBS AM's Nutrien position peaked at $103M in Q2 2018.
747 funds tracked by Wall St. Rank held Nutrien as of Q1 2026.

Based on UBS AM's 13F filing for Q1 2026, filed 13 May 2026.